{"id":"NCT01994720","sponsor":"AstraZeneca","briefTitle":"[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]","officialTitle":"A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-01-07","primaryCompletion":"2016-03-02","completion":"2016-03-02","firstPosted":"2013-11-26","resultsPosted":"2017-06-12","lastUpdate":"2017-06-12"},"enrollment":13307,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Acute Ischaemic Stroke","Transient Ischaemic Attack"],"interventions":[{"type":"DRUG","name":"ticagrelor","otherNames":[]},{"type":"DRUG","name":"Acetylsalicylic acid (ASA)","otherNames":[]}],"arms":[{"label":"ticagrelor","type":"EXPERIMENTAL"},{"label":"Acetylsalicylic acid (ASA)","type":"ACTIVE_COMPARATOR"}],"summary":"The primary objective of the study is to compare the effect of 90-day treatment with ticagrelor (180 mg \\[two 90 mg tablets\\] loading dose on Day 1 followed by 90 mg twice daily maintenance dose for the remainder of the study) vs acetylsalicylic acid (ASA)-aspirin (300 mg \\[three 100 mg tablets\\] loading dose on Day 1 followed by 100 mg once daily maintenance dose for the remainder of the study) for the prevention of major vascular events (composite of stroke, myocardial infarction \\[MI\\], and death) in patients with acute ischaemic stroke or transient ischaemic attack (TIA).","primaryOutcome":{"measure":"Number of Participants With Composite of Stroke/MI/Death","timeFrame":"From randomization up to 97 days","effectByArm":[{"arm":"Ticagrelor 90 mg","deltaMin":442,"sd":null},{"arm":"ASA 100 mg","deltaMin":497,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0670"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":1},"locations":{"siteCount":521,"countries":["United States","Argentina","Australia","Belgium","Brazil","Bulgaria","Canada","Chile","China","Czechia","France","Germany","Hong Kong","Hungary","Israel","Italy","Japan","Mexico","Peru","Philippines","Poland","Romania","Russia","Slovakia","South Korea","Spain","Sweden","Switzerland","Taiwan","Thailand","Turkey (TÃ¼rkiye)","Ukraine","Vietnam"]},"refs":{"pmids":["35538232","32666831","31296654","31092152","30776996","29915123","28720658","28655834","28238711","27899747","27160944","27160892"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=1836&filename=d5134c00001-revised-csp-2-redacted_1July2015.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":533,"n":6581},"commonTop":["Dyspnoea"]}}